Israele - ebraico - Ministry of Health

vetmarket marketing ltd - fusidic acid as hemihydrate 1 % - eye drops - for the topical treatment of conjunctivitis in the dogs and cats associated with staphylococcus aureus and in particular the biotype staphylococcus intermedius. for the topical treatment of conjunctivitis in the dogs and cats associated with secondary staphylococcal infections.

Israele - ebraico - Ministry of Health

pfizer pharmaceuticals israel ltd - cefovicin as sodium salt 80 mg/dose - powder for solution for injection - dogs : for the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. for the treatment of urinary tract infections associated with escherichia coli and/or proteus spp. as adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with porphyromonas spp. and prevotella spp.cats : for the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. for the treatment of urinary tract infections associated with escherichia coli.

Israele - ebraico - Ministry of Health

intervet ( israel) ltd - cefquinome as sulfate - תרחיף להזרקה - cefquinome as sulfate 25 mg/ml

Israele - ebraico - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fusidic acid 2 % - cream - fusidic acid - local treatment of skin infections due to sensitive strains of staphylococcus aureus

Israele - ebraico - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fusidic acid - קרם - fusidic acid 2 % - fusidic acid - fusidic acid - local treatment of skin infections due to sensitive strains of staphylococcus aureus

Israele - ebraico - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

Israele - ebraico - Ministry of Health

bayer israel ltd - moxifloxacin - תמיסה לאינפוזיה - moxifloxacin 400 mg / 250 ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

Israele - ebraico - Ministry of Health

dexcel ltd, israel - sodium fusidate - טבליה - sodium fusidate 250 mg - fusidic acid - fusidic acid - for the treatment of infections caused by staphylococcus.

Israele - ebraico - Ministry of Health

medison pharma ltd - daptomycin 500 mg/vial - lyophilized powder for injection - daptomycin - cubicin (daptomycin for injection) is indicated for the treatment of complicated skin and skin structure infections caused by susceptible strains of the following gram-positive microorganisms: staphylococcus aureus (including methicillin-resistant strains) streptococcus pyogenes streptococcus agalactiae streptococcus dysgalactiae subsp. equisimilis and enterococcus faecalis (vancomycin-susceptible strains only). combination therapy may be clinically indicated if the documented or presumed pathogens include gram-negative or anaerobic organisms. daptomycin is not indicated for the treatment of pneumonia. appropriate specimens for microbiological examination should be obtained in order to isolate and identify the causative pathogens and to determine their susceptibility to daptomycin. empiric therapy may be initiated while awaiting test results. antimicrobial therapy should be adjusted as needed based upon test results. to reduce the development of drug-resistant bacteria and maintain the effectiveness of cubici

Israele - ebraico - Ministry of Health

biovac ltd, israel - sulfadimethoxine sodium 13.35 %w/v; trimethoprim 2.5 %w/v - solution - treatment of bacterial infections caused by: e.coli, salmonella, pastorella, staphylococcus, streptococcus and other bacteria sensitive to sulphonamides and trimethoprim in turkeys.